|
Real-time Estimate
Cboe BZX
19:47:47 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 15.20 USD | -0.30% |
|
-16.01% | -57.92% |
| 07:12pm | UBS Adjusts Price Target on Mineralys Therapeutics to $19 From $29, Keeps Neutral Rating | MT |
| 11-05 | Mineralys Therapeutics, Inc., Q3 2026 Earnings Call, Nov 04, 2026 |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MLYS | Delayed | |
CBOE
| MLYS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 20.55 | 20.55 | 28.21 |
| Spread/Res. | -25.69% | -25.69% | -45.87% |
| Spread/Supp. | +29.74% | +29.74% | +0.93% |
| Support | 11.77 | 11.77 | 15.13 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MLYS Stock
- Charts Mineralys Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
